Stem cell research in urology can be broadly subdivided into two fields: one that attempts to identify urological tissue-specific stem cells; and another that tries to apply lessdifferentiated multipotent stem cells, such as embryonic stem cells (ESCs), to the treatment of urological diseases. Several studies have investigated tissue-specific stem cells in the kidney, bladder, prostate, penis and testes. The main obstacles in this field of research are the lack of reliable markers for putative tissue-specific stem cells, and the absence of a convincing rationale to justify their use over less-differentiated stem cells, which offer more therapeutic flexibility and are usually more-easily accessible.
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